As of 2026-09-13, the EV/EBITDA ratio of ImmunoGen Inc (IMGN) is -105.37. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IMGN's latest enterprise value is 8,216.60 mil USD. IMGN's TTM EBITDA according to its financial statements is -77.98 mil USD. Dividing these 2 quantities gives us the above IMGN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 16.0x - 17.1x | 16.5x |
| Forward P/E multiples | 19.1x - 21.3x | 20.0x |
| Fair Price | (3.52) - (2.95) | (3.28) |
| Upside | -111.3% - -109.4% | -110.5% |
| Date | EV/EBITDA |